Table 3.
Prevalence and incidence of stages 3 and 4 CKD in the white participants of a US cohort (NHANES) (21), a Norwegian cohort (HUNT) (14), and a Dutch Cohort (PREVEND) (10)
| Parameter | Country/Study | ||
|---|---|---|---|
| Norway/HUNTa | Netherlands/PREVEND | United States/NHANESa | |
| Prevalence stages 3 and 4 | 4360/100,000 | 5300/100,000 | 5010/100,000 |
| Incidence ESRDb | 10.6/100,000 | 10.0/100,000 | 30.8/100,000 |
| Incidence as % of prevalence | 0.24 | 0.19 | 0.61 |
a
The data of the HUNT and NHANES studies were derived from reference (14). The data from that study were stratified by age, gender, and diabetes status. The mean age of the HUNT patients was 50.2 yr and of the PREVEND patients was 48.7 yr.
b
Data on incidence of ESRD have been derived from the respective national renal replacement registries.